Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2025-12-26 @ 7:14 PM
Study NCT ID:
NCT00158860
Status:
COMPLETED
Last Update Posted:
2019-02-15
First Post:
2005-09-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-06-21
Start Date Type:
ACTUAL
Primary Completion Date:
2006-07-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-07-26
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-08
First Submit QC Date:
None
Study First Post Date:
2005-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-06
Results First Submit QC Date:
None
Results First Post Date:
2019-02-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-28
Last Update Post Date:
2019-02-15
Last Update Post Date Type:
ACTUAL